This stock have been following a trend line for a long time. I don't see why it should stop.
Stock oversold, and price at SMA200.
As always. Target is floating and not set. If the trade is successful, I will close once it hit's SMA200 again.
The candles keep side way and flat due to the uncertainty whether or not FDA will approve a drug, Kyndrisa, If Kyndrisa is not approved, it will negatively impact BioMarin’s share price. However, if it is approved, Kyndrisa will result in high profits for the company.
So wait and see.